Risk Analysis for Merck and Company: Product KL-798 Harvard Case Solution & Analysis

This case is based on the case of «Merck & Company: KL-798 Product" by providing market uncertainty for the drug (product quality, presence of competitors, market growth, and time of the drug). Detailed information and tables are designed to calculate the net present value for the scenarios. There is the additional problem of how to treat multiple downstream solutions (using OptQuest, for example), and as a valued license opportunities. "Hide
by Samuel E injuries, John H. Falk Source: Darden School of Business 8 pages. Date Published: September 25, 2002. Prod. #: UV0365-PDF-ENG

Related Case Solutions & Analyses:

Compulsory Licensing Thailand and Abbott Laboratories John Smithers at Sigtek New York City Against AIDS Video Merck & Co. Inc. (A) Ocean Park Corporation (Hong Kong) Tanzania Case Study Brand Recovery: Communication in the Face of Crisis Challenge the Boss or Stand Down Strategic Financial Planning in Mining Industry Steve Rogers Case Study